Mass spectrometry offers a versatile and robust platform to discover and characterize new diagnostic, prognostic, and therapeutic biomarkers for disease, elucidate and understand pathways including protein-protein interactions, visualize endogenous and exogenous compound distributions in tissues via mass spectrometry imaging, and characterize post-translational modifications. Moreover, a Multi-OMIC approach will allow the underlying biology to be defined, enabling modeling of pathways and identify potential drug targets. This presentation will focus on different approaches to more effectively and quantitatively measure <i>N</i>-linked glycans. These approaches are made possible by innovations in chemistry and novel ionization sources developed in our laboratory. The fundamentals of these strategies will be integrated throughout the presentation.

From LC-MS and LC-IM-MS glycomics to mass spectrometry imaging: Novel chemistry to platform technologies with diverse applications in human health and disease

Fall 2022 abstracts, posters, and presentations will launch in mid-September.

ACS Fall 2022

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.